Cannabinol

Cronos Group Reports 2024 First Quarter Results

Retrieved on: 
星期四, 五月 9, 2024
Cream, Mazor Robotics, Genetics, Certified Public Accountant, Wedding cake, Investment, Fully Charged, Average cost, Capital, EY, Pharma, Depreciation, Cannabinol, Flower, Robotics, Traction, GMO, Partnership, Research, Capital expenditure, Medtronic, Tax, Senior, Patient, Vii, Hamas, CBC, Motus, CBN, Lord, CBG, Growth, Drug

TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2024 first quarter business results.

Key Points: 
  • Cronos Growing Company Inc. ("Cronos GrowCo") reported to the Company preliminary unaudited net revenue to licensed producers, excluding sales to the Company, of approximately $5.1 million in the first quarter of 2024.
  • Cronos previously provided Cronos GrowCo with a senior secured credit facility, which currently has approximately $67.1 million outstanding following a principal repayment of $1.2 million by Cronos GrowCo in Q1 2024.
  • In addition to principal repayment, Cronos also received $1.4 million in interest payments from Cronos GrowCo, totaling approximately $2.7 million in cash payments to Cronos in Q1 2024.
  • Before becoming Head of Cronos Israel, he was the Vice President of Finance at Cronos Israel managing the Cronos Israel finance department.

CBDistillery™ shhh+ Distilled Deep Sleep Gummies Deliver Better Sleep, Improved Quality of Life

Retrieved on: 
星期二, 四月 23, 2024
Pathfinder, THC, Cannabinol, Partnership, Quality of life, CBN, Sleep

The 31-day Pathfinder study, conducted by CBDistillery™ in partnership with MoreBetter’s (dba Releaf App™ ) highly rated tracking technology, analyzed the ways in which gummies containing hemp-derived CBD, Delta-9 tetrahydrocannabinol (THC), and cannabinol (CBN) can improve sleep.

Key Points: 
  • The 31-day Pathfinder study, conducted by CBDistillery™ in partnership with MoreBetter’s (dba Releaf App™ ) highly rated tracking technology, analyzed the ways in which gummies containing hemp-derived CBD, Delta-9 tetrahydrocannabinol (THC), and cannabinol (CBN) can improve sleep.
  • The results showed that participants who regularly took one shhh+ Distilled Deep Sleep gummy per night found it easier to stay asleep throughout the night while also reporting improved quality of sleep throughout the study.
  • 98% shared that CBDistillery™’s shhh+ Distilled Deep Sleep Gummies had only a positive impact on their quality of life;
    91% would recommend CBDistillery™’s shhh+ Distilled Deep Sleep Gummies to others;
    79% found it was easier to fall back asleep after waking up during the night after using CBDistillery’s shhh+ Distilled Deep Sleep Gummies compared to when they did not take it;
    77% stated CBDistillery™’s shhh+ Distilled Deep Sleep Gummies performed better than any other sleep aid product previously used; and,
    74% woke up feeling more refreshed after using CBDistillery™’s shhh+ Distilled Deep Sleep Gummies.
  • We look forward to continuing this journey and sharing more insights with our community,” said Bill Stoufer, President of Balanced Health Botanicals.

Charlotte's Web Launches" Stay Asleep" CBN Gummies

Retrieved on: 
星期二, 三月 19, 2024
Cannabinoid, Entrepreneurship, Science, Sleep, GMO, Charlotte's Web, News, CBD, CWEB, Stay Asleep, TSX, CBN, Web, Cannabinol, Pharmaceutical industry

LOUISVILLE, Colo., March 19, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the leading provider of hemp-derived CBD wellness products, has formally launched its latest innovation, "Stay Asleep" CBN Gummies.

Key Points: 
  • LOUISVILLE, Colo., March 19, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the leading provider of hemp-derived CBD wellness products, has formally launched its latest innovation, "Stay Asleep" CBN Gummies.
  • The launch of Charlotte's Web Stay Asleep CBN Gummies is a testament to this commitment.
  • Developed under the leadership of Charlotte's Web's Chief Scientific Officer, Dr. Marcel Bonn-Miller, the Stay Asleep CBN Gummies demonstrate Charlotte's Web commitment to science-backed products, providing an effective alternative to more traditional sleep supplements and medications.
  • With millions of Americans grappling with sleep issues1, the Stay Asleep CBN Gummies embody Charlotte's Web's mission to unearth the science of nature to revolutionize wellness.

Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹

Retrieved on: 
星期四, 二月 29, 2024
Shekel, Vii, Peace, Pressure, Research, Investment, Flower, Average cost, Growth, CBN, Sale, Cannabinoid, Wind, Capital expenditure, Genetics, CBG, GMO, Edible, Patient, CBD, Tax, CBC, Capital, Cannabinol, Lord, Bank statement, Depreciation, Drug

In Israel, Cronos launched three new flower offerings under the Peace Naturals® brand in the fourth quarter, Rockstar, Dancehall, and Sonic Fuel.

Key Points: 
  • In Israel, Cronos launched three new flower offerings under the Peace Naturals® brand in the fourth quarter, Rockstar, Dancehall, and Sonic Fuel.
  • Cronos GrowCo reported to the Company preliminary unaudited net revenue to licensed producers excluding sales to the Company in the fourth quarter and full-year 2023 of approximately $6.6 million and $19.6 million, respectively.
  • In addition to principal repayment, Cronos also received approximately $10.3 million in interest payments from GrowCo in 2023, resulting in a total of approximately $15.9 million in cash payments to Cronos in 2023.
  • ET to discuss 2023 Fourth Quarter and Full-Year business results.

Pervasip Announces Financial Results for Fiscal Year 2023

Retrieved on: 
星期四, 二月 29, 2024
Financial audit, Biomass, PVSP, Net income, Psilocybin, Cannabinol, Bank statement, Cryptocurrency

SEATTLE, WA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its fiscal years ended November 30, 2023.

Key Points: 
  • SEATTLE, WA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the filing of its unaudited financial statements for its fiscal years ended November 30, 2023.
  • Operating Loss for the year ending November 30, 2023 totaled ($460,037), compared to an operating loss of $2,422,916 during the same period in 2022.
  • Cashflow for the year ending November 30, 2023 totaled $409,507, compared to negative cashflow of ($798,033) during the same period in 2022.
  • Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin.

New Farm Bill-Compliant CBD and Hemp Seed Payment Gateways Now Available

Retrieved on: 
星期三, 一月 17, 2024
Online, Seed, Gold, Cannabinol, Vitamin, Policy, B2C, BBB, WooCommerce, Sale, BigCommerce, Dietary supplement, WordPress, THC, Plant, Online shopping

With these new payment processing options, American hemp and CBD businesses can showcase the quality and potential of their seeds.

Key Points: 
  • With these new payment processing options, American hemp and CBD businesses can showcase the quality and potential of their seeds.
  • Organic Payment Gateways allows businesses to efficiently sell their hemp and CBD products by providing hassle-free online payment processing.
  • Organic Payment Gateways provides specialized, user-friendly payment gateways tailored to CBD and hemp seed businesses' unique needs.
  • Website owners in the CBD and hemp seed industries can now experience the convenience and flexibility of the new payment acceptance options offered by Organic Payment Gateways.

Healthcare Industry Veteran Donald M. Casey Jr. Joins Board of Directors at Cannabinoid Biotech Leader FloraWorks

Retrieved on: 
星期四, 一月 4, 2024
Entrepreneurship, Cannabinoid, Johnson & Johnson, Sleep, Cardinal Health, Health, Diabetes, Hospital, CBN, Alzheimer's disease, Cannabinol, Pharmaceutical industry

Portland, Oregon--(Newsfile Corp. - January 4, 2024) - FloraWorks Holdings Inc. , a leading cannabinoid biotech company, announced the appointment of Donald M. Casey Jr. as Board Director.

Key Points: 
  • Portland, Oregon--(Newsfile Corp. - January 4, 2024) - FloraWorks Holdings Inc. , a leading cannabinoid biotech company, announced the appointment of Donald M. Casey Jr. as Board Director.
  • Casey brings over 30 years of global healthcare experience to the FloraWorks board, with an outstanding track record of identifying and commercializing medical innovations.
  • "Casey is a proven leader in healthcare operations and will be an integral perspective on our board of directors," said Alleh Lindquist , CEO and Co-Founder of FloraWorks.
  • This study marks the first cannabinoid to be clinically validated to promote better sleep.

Cannabinol (CAS 521-35-7) Global Market Research Report 2023: Applications, Manufacturing Methods, Patents, Pricing and Major End-Use Sectors - ResearchAndMarkets.com

Retrieved on: 
星期一, 十一月 20, 2023
Alternative Medicine, Manufacturing, Other Health, Health, Cannabis, Pharmaceutical, Other Science, Natural Resources, Research, Science, Chemicals, Plastics, CAS, Intellectual property, Book, Cannabinol

The "Cannabinol (CAS 521-35-7) Global Market Research Report 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cannabinol (CAS 521-35-7) Global Market Research Report 2023" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Cannabinol.
  • The Cannabinol global market report offers a comprehensive overview of Cannabinol, covering various key points to provide valuable insights for businesses and stakeholders.
  • In summary, the Cannabinol global market report offers a comprehensive and structured approach to understanding Cannabinol, making it an invaluable resource for businesses and stakeholders operating in this dynamic market.

Introducing Rare Cannabinoid Company's Latest Innovation: THC + CBN Sleep Gummies for a Restful Night's Sleep

Retrieved on: 
星期三, 十一月 22, 2023
Sleep, Safety, THC, Oil, Gummy candy, CBN, Multimedia, Rest, THCV, Ship, Cannabinol, Relaxation, CBG, Gum arabic, Hotel, CBD

HONOLULU, Nov. 22, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company, a leading provider of premium hemp-infused products, is thrilled to announce the launch of their newest product, THC + CBN Sleep Gummies. Crafted with care and designed to promote a restful night's sleep, these gummies are set to revolutionize the way people experience CBN products.

Key Points: 
  • HONOLULU, Nov. 22, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company, a leading provider of premium hemp-infused products, is thrilled to announce the launch of their newest product, THC + CBN Sleep Gummies .
  • THC + CBN Sleep Gummies offer a natural and effective option for those seeking a better night's sleep.
  • Legal Delta-9-THC Gummies: The Delta-9-THC in THC + CBN Sleep Gummies comes in a full spectrum oil that is naturally extracted from legal U.S. hemp plants.
  • They are also releasing THC + CBG Relief Gummies and THC + THCV Uplift Gummies to add to their growing THC Gummies line.

Wyld Introduces New Boysenberry Sleep Gummies

Retrieved on: 
星期二, 十一月 14, 2023
Sleep, CBN, Cannabinol, Terpene, Cannabinoid, Cannabis, Climate, THC, Pomegranate, Marketing, Cannabidiol, CBD

CLACKAMAS, Ore., Nov. 14, 2023 /PRNewswire/ -- Wyld, one of the top five cannabis brands in the U.S., known for their best-selling cannabis infused edibles, is introducing a new sleep gummy, Boysenberry 1:1:1 THC:CBD:CBN Indica-enhanced, across the country.

Key Points: 
  • CLACKAMAS, Ore., Nov. 14, 2023 /PRNewswire/ -- Wyld, one of the top five cannabis brands in the U.S., known for their best-selling cannabis infused edibles, is introducing a new sleep gummy, Boysenberry 1:1:1 THC:CBD:CBN Indica-enhanced, across the country.
  • The boysenberry gummy is Wyld's first to include three cannabinoids – THC, CBD (cannabidiol), and CBN (cannabinol) – as well as botanical terpenes.
  • This addition to Wyld's sleep collection joins their Elderberry 2:1 THC:CBN gummy, which is the bestselling cannabis edible in the country according to BDSA data.
  • Wyld's Boysenberry Indica-enhanced gummies is available in the U.S.